Advanz Pharma (OTCMKTS:CXRXF) Trading 2.6% Higher

Shares of Advanz Pharma Corp (OTCMKTS:CXRXF) traded up 2.6% during mid-day trading on Friday . The stock traded as high as $3.16 and last traded at $3.16, 1,895 shares were traded during mid-day trading. The stock had previously closed at $3.08.

The company has a quick ratio of 2.04, a current ratio of 2.37 and a debt-to-equity ratio of 86.79. The company has a fifty day moving average of $3.35 and a 200-day moving average of $4.24.

Advanz Pharma (OTCMKTS:CXRXF) last posted its quarterly earnings data on Wednesday, May 13th. The company reported ($0.18) earnings per share (EPS) for the quarter. Advanz Pharma had a negative net margin of 39.13% and a negative return on equity of 191.06%. The firm had revenue of $129.99 million during the quarter.

About Advanz Pharma (OTCMKTS:CXRXF)

ADVANZ PHARMA Corp., a specialty pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products. The company operates through two segments, Concordia International and Concordia North America. The Concordia International segment owns or licenses a portfolio of branded and generic prescription products to wholesalers, hospitals, and pharmacies.

Further Reading: Market Capitalization and Individual Investors

Receive News & Ratings for Advanz Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanz Pharma and related companies with MarketBeat.com's FREE daily email newsletter.